Eisai
4523.T
#2304
Rank
A$11.78 B
Marketcap
A$41.76
Share price
2.66%
Change (1 day)
-7.34%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.24. an increase over its 2024 EPS that were of A$1.40.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.5711.85%
2024A$1.40-32.63%
2023A$2.085.52%
2022A$1.97-74.01%
2021A$7.59-66.58%
2020A$22.7098.24%
2019A$11.4517.01%
2018A$9.7937.78%
2017A$7.10-27.62%
2016A$9.8135.33%
2015A$7.25-2.82%
2014A$7.46-27.66%
2013A$10.31-27.49%
2012A$14.23-12.67%
2011A$16.2988.08%
2010A$8.66-11.06%
2009A$9.74-390.15%
2008A-$3.36-127.78%
2007A$12.0811.78%
2006A$10.814.38%
2005A$10.367.4%
2004A$9.6443.03%
2003A$6.7425.09%
2002A$5.3952.67%
2001A$3.5369.76%
2000A$2.08